title: Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
authors.forename: Andrea
authors.initials: A
authors.lastname: Santamato
authors.forename: Francesco
authors.initials: F
authors.lastname: Panza
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Solfrizzi
authors.forename: Vincenza
authors.initials: V
authors.lastname: Frisardi
authors.forename: Maurizio
authors.initials: M
authors.lastname: Ranieri
authors.forename: Piero
authors.initials: P
authors.lastname: Fiore
mesh_terms: D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A